Latest updates on oncology treatments including FDA approval of new Amivantamab dosage, management of immune-checkpoint inhibitor toxicities, and fast-track designation…
Day: January 16, 2026
EU Approval of Inavolisib Combo for Breast Cancer and Other Oncology Advancements
Discover the latest advancements in oncology including the EUs approval of Inavolisib combo for breast cancer and more.